Dr. Christopher Fragassi, MD

Dr. Fragassi practices at Wyoming Valley Behavioral Health in Kingston, Pennsylvania, part of Wyoming Valley Behavioral Health.

Dr. Fragassi's NPI, 1164927935, was assigned on March 26, 2018. Dr. Fragassi holds Pennsylvania license MD474966.

Dr. Fragassi's primary practice is Wyoming Valley Behavioral Health, at 562 Wyoming Avenue, Kingston, PA 18704.

Dr. Fragassi's primary practice is Wyoming Valley Behavioral Health in Kingston, Pennsylvania, part of Wyoming Valley Behavioral Health. Dr. Fragassi is also affiliated with Regional Hospital of Scranton. The medical group on file is Matthew Berger, MD. Dmand AI also links Dr. Fragassi to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fragassi practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Fragassi's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Fragassi is licensed in Pennsylvania.

CMS data shows 710 Medicare services from Dr. Fragassi across 4 procedure codes in 2024, for 130 Medicare patients. Medicare paid $49,015 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Fragassi in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have anxiety, and 75% have depression. 38% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fragassi's median patient age at 52, with 46% women.

In 2024, Dr. Fragassi wrote 1,494 Medicare Part D claims for 150 patients. 94% of them were for generic drugs. CMS names the drug for 1,111 of them, across 36 drugs with 11 or more claims each, at $16,404 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

Dr. Fragassi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fragassi as offering telehealth.

Dmand AI links 2 papers to Dr. Fragassi, published from 2020 to 2021. The most frequent topics are Mental Health and Research Design. Dr. Fragassi has published most often in PLoS One. Dr. Fragassi's most frequent co-authors are Desiree Li, MD, Omar Sahak, MD, MPH and Thanh Dieu Truong.

CMS Open Payments shows 47 general payments to Dr. Fragassi from 12 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $520.